Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study

The lack of translation from basic research into new medicines is a major challenge in CNS drug development. The need to use novel approaches relying on (i) patient clustering based on neurobiology irrespective to symptomatology and (ii) quantitative biomarkers focusing on evolutionarily preserved n...

Descripción completa

Detalles Bibliográficos
Autores principales: Loiodice, Simon, Drinkenburg, Wilhelmus H., Ahnaou, Abdallah, McCarthy, Andrew, Viardot, Geoffrey, Cayre, Emilie, Rion, Bertrand, Bertaina-Anglade, Valérie, Mano, Marsel, L’Hostis, Philippe, Drieu La Rochelle, Christophe, Kas, Martien J., Danjou, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085207/
https://www.ncbi.nlm.nih.gov/pubmed/33927180
http://dx.doi.org/10.1038/s41398-021-01371-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085207/
https://www.ncbi.nlm.nih.gov/pubmed/33927180
http://dx.doi.org/10.1038/s41398-021-01371-1

Ejemplares similares